WallStreetZenWallStreetZen

NASDAQ: NRSN
Neurosense Therapeutics Ltd Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Neurosense Therapeutics earnings were -$11.1M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest NRSN earnings report on Dec 31, 2025 announced Q4 2025 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, NRSN reported annual earnings of -$11.1M, with 9% growth.

NRSN earnings history

Current Revenue
$0.0
Current Earnings
-$11.1M
Current Profit Margin
0%

NRSN Return on Equity

Current Company
-2,175%
Current Industry
-31.4%
Current Market
28.9%
NRSN's Return on Equity (-2,175%)... subscribe to Premium to read more.
High Return on Equity Performance

NRSN Return on Assets

Current Company
-397.1%
Current Industry
-9.6%
NRSN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when NRSN announces earnings.

NRSN Return on Capital Employed

Current Company
747.65%
Current Industry
-3.7%
NRSN has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

NRSN vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
NRSN-$11.11M-$11.13MN/A-$0.44
NXTC-$52.25M-$54.66MN/A-$17.19
RKTO-$11.69M-$11.69MN/A-$0.80
KTTA-$19.08M-$19.73MN/A-$2.08
CYCN-$5.28M-$5.28MN/A-$1.36
View Top Biotech Stocks

Neurosense Therapeutics Earnings Reports & History FAQ

What were Neurosense Therapeutics's earnings last quarter?

On NRSN's earnings call on Mar 25, 2026, Neurosense Therapeutics (NASDAQ: NRSN) reported Q4 2025 earnings per share (EPS) of N/A, up N/A year over year. Total NRSN earnings for the quarter were N/A. In the same quarter last year, Neurosense Therapeutics's earnings per share (EPS) was -$0.06.

If you're new to stock investing, here's how to buy Neurosense Therapeutics stock.

Is Neurosense Therapeutics profitable or losing money?

As of the last Neurosense Therapeutics earnings report, Neurosense Therapeutics is currently losing money. Neurosense Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2025 was -$11.13 million, a 8.96% increase year over year.

What was NRSN's earnings growth in the past year?

As of Neurosense Therapeutics's earnings date in Mar 25, 2026, Neurosense Therapeutics's earnings has grown year over year. NRSN earnings in the past year totalled -$11.13 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.